StartseiteLogbuch - AktuellesSchwerpunktthemenVeranstaltungenVorträge - StellungnahmenHerschels HeresiesPublikationenZur PersonBuchempfehlungen

Publikationen:

Bücher

Dissertation

Essays

Fachartikel

Literaturverzeichnis

Allgemein:

Startseite

Sitemap

Kontakt

Impressum

Bergmann L., Warncke W., Herschel M.
Bupropion SR als Unterstützung in der Raucherentwöhnung rückfälliger Raucher: Ergebnisse einer offenen multizentrischen Studie in Deutschland
Pneumologie 2004; Mar; 58(3): 140-146

Beck J., Esser P.J., Herschel M.
Why clinical trials fail before they get even started: the frontloading process
Qual Assur J 2004; 8: 21-32

Herschel Michael
Das KliFo Buch
Praxisbuch Klinische Forschung
Schattauer Verlag, 2009

Herschel M., Meyer-Pannwitt U.
Collaborative centre for clinical research and development at the community hospitals of Hamburg
Int J Pharmaceutical Medicine 1999

Kurscheid T. et al.
Prozeßkostenanalyse der PTCA
Gesundh.ökonom.Qual.manag. 1999 (4): 74-84

Herschel M., Beck J.
Negative attitudes to clinical trials are not an external problem for clinical trials.
Pharmacopsyciatry 1991; May; 24(3): 103

Pinter M.M. et al.
Pramipexole in advanced Parkinson`s disease: a double-blind, placebo-controlled, randomized multicenter trial. (Abstracxt 8-17-02)
Can J Neurol Sci 1993, suppl. 4 : 234

Clarenbach P. et al.
Talipexole : effects and tolerability in a double-blind, controlled, randomized trial in advanced Parkinson`s disease.(Abstract P 274)
Movement Disorders 1992; 7/suppl. 1 : 99

Herschel M.
A double-blind trial of clenbuterol vs. maprotiline in major depressive disorder (Abstract P-25-27)
Biol Psychiatry 1991; 29: 621S

Herschel M., Leonard J.P.
Brotizolam in der Behandlung von Schlafstörungen.
Münch Med Wschr 1991; 133: 109-112

Greulich W. et al..
Talipexole : effects and tolerance in a double-blind, placebo-controlled , randomized study in advanced Parkinson`s disease (Abstract F-08-03)
10th International Symposium on Parkinson`s Disease, Tokyo, 1991


Dahlke F. et al.
Recommendations for clinical trials of drugs indicated for dementing illness.
Nervenarzt 1991; 62 : 256-259

Herschel M.
Clonidin im Entzugsdelir : Wirkung auf die psychische Symptomatik
In: Benos J (ed.) Psychopathometrie und Suchtkrankheiten, Ebersberg 1990, pp. 111-122

Herschel M.
The dopamine receptor, target of various diseases
Fortschr Med 1987; 105/5 : 86-88

Campbell A. et al.
Circadian changes in the distribution and effects of haloperidol in rat.
Neuropharmacology 1982; 21: 663-669

Baldessarini R.J. et al.
Chronopsychopharmacology.
Psychopharmacol Bull 1981; 17: 112-113

Arana G.W. et al.
Improved high-affinity binding of (3H)-apomorphine with a subcellular membrane fraction of mammalian brain tissue.
Life Sciences 1981; 29: 121-133

Cohen B.M. et al.
Radioreceptor assay of haloperidol in the rat.
Neuropharmacology 1980; 19: 663-668

Campbell A. et al.
Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the rat.
Life Sciences 1980; 27: 633-640

Herschel M. Baldessarini R.J.
Evidence for two types of (3H)-GABA and (3H)-muscimol binding in rat cerebral cortex and cerebellum.
Life Sciences 1979; 24: 1849-1854

Cohen B.M. et al.
Neuroleptic, antimuscarinic, and anti-adrenergic activity of chlorpromazine, thioridazine, and their metabolites.
Psychiatric Res 1980; 1: 199-208

Campbell A. et al.
Diurnal changes in effects of haloperidol and metabolism of haloperidol in rat (Abstract No. 241.8)
Soc Neurosci Abstr 1980; 6: 707

Baldessarini R.J. et al.
Radioreceptor assay for neuroleptics (Abstract NR-36)
American Psychiatric Association New Research Abstracts, May , 1979

Herschel M.
Dyslexia revisited - a review.
Hum Genet 1978; 40: 115-134

Kopun M., Herschel M.
Determination of dopamine-beta-hydroxylase activity by means of chromatogram spectrofluorimetric measurement in remission.
Anal Biochem 1978; 85: 556-563

Winter H. et al.
A twin study on three enzymes (DBH, COMT, MAO) of catecholamine metabolism.
Psychopharmacol 1978; 57: 63-69